Latest / Lung Cancer Considered
IASLC - EGFR Mutant NSCLC Post Osimertinib
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a new Virtual Tumor Board on EGFR mutant NSCLC and acquired resistance. Dr. Liu is joined by two thoracic medical oncologists who are both global experts in targeted therapy.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.